{"id":"W4408780248","doi":"10.3390/curroncol32040187","title":"Real-World Clinical Outcomes with First-Line Systemic Treatment and Avelumab Maintenance in US Patients with Locally Advanced or Metastatic Urothelial Carcinoma: The SPEAR Bladder-II Study","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"EMD Serono; Pfizer","keywords":"Avelumab; Medicine; Discontinuation; Metastatic Urothelial Carcinoma; Carboplatin; Internal medicine; Oncology; Bladder cancer; Population; Cisplatin; Nivolumab; Chemotherapy; Cancer; Urothelial carcinoma; Immunotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00102687,0.0002312208,0.0004974986,0.0006892433,0.0002682142,0.0007591184,0.000409366,0.0004433797,0.001001101],"category_scores_gemma":[0.003035784,0.0002272006,0.0008943974,0.001414883,0.0002243223,0.0007644562,0.0006541851,0.0006810245,0.0002361239],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000728394,"about_ca_system_score_gemma":0.0005088649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003993088,"about_ca_topic_score_gemma":0.005918221,"domain_scores_codex":[0.9992262,0.0002267225,0.000140542,0.0001945212,0.0001078312,0.0001041421],"domain_scores_gemma":[0.996532,0.0004367872,0.002141096,0.000236529,0.0002384899,0.0004151218],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009918264,0.00007190209,0.9954716,0.00003405561,0.0002265301,0.00005981107,0.00005579989,0.0001976187,0.000113957,0.0000229153,0.0004305469,0.002323569],"study_design_scores_gemma":[0.0001103007,0.000460512,0.99708,0.00002520299,0.0001761584,0.0004248114,0.0001545905,0.0005217426,0.000125549,0.00002862043,0.0008784492,0.00001397666],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956181,0.0006883548,0.00007159208,0.0000658612,0.000008104291,0.00002289923,0.003011947,0.000004659481,0.0005085416],"genre_scores_gemma":[0.993905,0.0002363559,0.0000830121,0.00005850654,0.00001688205,0.00003063339,0.005540966,0.000004287369,0.0001243674],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003993088,"threshold_uncertainty_score":0.007939696,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06938084763196287,"score_gpt":0.4064602409107799,"score_spread":0.3370793932788171,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}